Biopharmaceuticals Market by Therapeutic Area (Autoimmune, Cardiovascular, Infectious Disease), Technology (Cell Culture, Gene Therapy, Hybridoma), Distribution Channel, Product Type, Route Of Administration, Distribution Channel

The biopharmaceuticals market is experiencing accelerated expansion, driven by scientific breakthroughs, regulatory innovation, and the realignment of global supply chains. As therapeutic development becomes more sophisticated and custom-tailored to patient needs, industry stakeholders must navigate new complexities and shifting market dynamics to maintain competitiveness.

Market Snapshot: Biopharmaceuticals Market Growth and Trajectory

The biopharmaceuticals market grew from USD 627.19 billion in 2024 to USD 690.04 billion in 2025. It is projected to continue expanding at a CAGR of 9.84%, reaching USD 1.10 trillion by 2030. Favorable global demand, increased innovation in therapeutic modalities, and strong investment flows are catalyzing this upward trend.

Scope & Segmentation

This biopharmaceuticals market analysis covers a comprehensive range of segments, technologies, channels, and regional breakdowns to support strategic decisions:

Therapeutic Areas: Autoimmune disorders, including inflammatory bowel disease, psoriasis, rheumatoid arthritis; cardiovascular diseases such as heart failure, hypercholesterolemia, hypertension; infectious disease with antibiotics, antivirals, vaccines; neurology focusing on Alzheimer’s, multiple sclerosis, Parkinson’s; oncology with hematological malignancies and solid tumors; rare diseases such as cystic fibrosis, hemophilia, lysosomal storage disorders.
Technology Platforms: Cell culture (mammalian, microbial), gene therapy (nonviral and viral vectors), hybridoma, recombinant DNA.
Distribution Channels: Direct to patient, hospital pharmacy, online pharmacy, retail pharmacy, direct sales, hospital pharmacies, online pharmacies, retail pharmacies.
Product Types: Biosimilars and generics supporting expanding market access.
Routes of Administration: Inhalation, intramuscular, intravenous, oral, subcutaneous, topical delivery options tailored for patient convenience.
Regions Covered: Americas (including the United States with coverage at the state level, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (with major markets such as the United Kingdom, Germany, France, Russia, and key countries across the Middle East and Africa); Asia-Pacific (China, India, Japan, Australia, South Korea, and major Southeast Asian economies).

Key Takeaways for Senior Decision-Makers

Advanced research in molecular biology and gene editing is accelerating the emergence of novel, personalized therapies addressing a wider range of complex conditions.
Enhanced collaboration across biotechs, contract manufacturers, and academia streamlines early-stage research and shortens commercialization timelines.
Expanding hybrid manufacturing and digital health platforms are creating flexible, cost-controlled production and enabling decentralized clinical trials.
Biosimilars and generics are gaining traction as cost-effective alternatives, driving broader global access and reshaping competitive strategies.
Investment in supply chain resilience and regulatory agility enables organizations to mitigate disruptions and navigate regional market entry effectively.
The evolving regulatory environment supports real-world evidence and adaptive approvals, offering new routes to market for innovative products.

Tariff Impact on the Biopharmaceuticals Market

New tariff structures in the United States are adding complexity for manufacturers that depend on cross-border supply of raw materials, reagents, and finished biologics. These adjustments increase production costs and press smaller innovators facing capital constraints to re-evaluate sourcing and production strategies. To address these risks, companies are diversifying supply bases, localizing manufacturing partnerships, leveraging digital procurement, and engaging in long-term logistics agreements to sustain continuity despite a volatile trade policy environment.

Methodology & Data Sources

This report is founded on rigorous secondary research, with extensive analysis of regulatory filings, scientific publications, and financial disclosures. Primary research includes interviews with industry executives across biotechnology, contract manufacturing, hospital procurement, and regulatory functions. Proprietary databases, scenario simulation, and robust segmentation frameworks underpin all findings.

Why This Report Matters

Enables data-driven investment and resource allocation by breaking down complex market and technology landscapes.
Supports strategic planning for growth, risk mitigation, and regulatory compliance in a rapidly changing environment.
Empowers stakeholders to identify high-value partnerships, optimize commercialization strategies, and enhance global market access.

Conclusion

The dynamic evolution of the biopharmaceuticals market demands agile, informed decision-making. Leveraging the insights and methodologies within this report can strengthen competitive positioning and accelerate delivery of advanced therapies for expanded patient benefit.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

5.1. Advancements in mRNA vaccine platforms enabling rapid development of personalized cancer immunotherapies
5.2. Integration of AI-driven drug discovery and predictive analytics to accelerate candidate selection
5.3. Expansion of cell and gene therapy manufacturing capacity to meet surge in global clinical trials
5.4. Adoption of digital biomarkers and remote patient monitoring to enhance real world evidence generation
5.5. Implementation of continuous biomanufacturing processes to reduce costs and streamline production pipelines
5.6. Growth of biosimilar development in emerging markets driving increased competition and cost reductions
5.7. Rising regulatory scrutiny on advanced therapy medicinal products reshaping global approval frameworks
5.8. Strategic partnerships between biopharma and AI startups accelerating precision medicine innovation cycles

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Biopharmaceuticals Market, by Therapeutic Area

8.1. Introduction
8.2. Autoimmune
8.2.1. Inflammatory Bowel Disease
8.2.2. Psoriasis
8.2.3. Rheumatoid Arthritis
8.3. Cardiovascular
8.3.1. Heart Failure
8.3.2. Hypercholesterolemia
8.3.3. Hypertension
8.4. Infectious Disease
8.4.1. Antibiotics
8.4.2. Antivirals
8.4.3. Vaccines
8.5. Neurology
8.5.1. Alzheimers
8.5.2. Multiple Sclerosis
8.5.3. Parkinsons
8.6. Oncology
8.6.1. Hematological Malignancies
8.6.2. Solid Tumors
8.7. Rare Disease
8.7.1. Cystic Fibrosis
8.7.2. Hemophilia
8.7.3. Lysosomal Storage Disorders

9. Biopharmaceuticals Market, by Technology

9.1. Introduction
9.2. Cell Culture
9.2.1. Mammalian
9.2.2. Microbial
9.3. Gene Therapy
9.3.1. Nonviral Vector
9.3.2. Viral Vector
9.4. Hybridoma
9.5. Recombinant Dna

10. Biopharmaceuticals Market, by Distribution Channel

10.1. Introduction
10.2. Direct To Patient
10.3. Hospital Pharmacy
10.4. Online Pharmacy
10.5. Retail Pharmacy

11. Biopharmaceuticals Market, by Product Type

11.1. Introduction
11.2. Biosimilars
11.3. Generics

12. Biopharmaceuticals Market, by Route Of Administration

12.1. Introduction
12.2. Inhalation
12.3. Intramuscular
12.4. Intravenous
12.5. Oral
12.6. Subcutaneous
12.7. Topical

13. Biopharmaceuticals Market, by Distribution Channel

13.1. Introduction
13.2. Direct Sales
13.3. Hospital Pharmacies
13.4. Online Pharmacies
13.5. Retail Pharmacies

14. Americas Biopharmaceuticals Market

14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina

15. Europe, Middle East & Africa Biopharmaceuticals Market

15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland

16. Asia-Pacific Biopharmaceuticals Market

16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan

17. Competitive Landscape

17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Roche Holding AG
17.3.2. Pfizer Inc.
17.3.3. Johnson & Johnson
17.3.4. Merck & Co., Inc.
17.3.5. AbbVie Inc.
17.3.6. Novartis AG
17.3.7. Sanofi S.A.
17.3.8. Bristol-Myers Squibb Company
17.3.9. Amgen Inc.
17.3.10. Gilead Sciences, Inc.

18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix

List of Figures

FIGURE 1. BIOPHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BIOPHARMACEUTICALS MARKET: RESEARCHAI
FIGURE 28. BIOPHARMACEUTICALS MARKET: RESEARCHSTATISTICS
FIGURE 29. BIOPHARMACEUTICALS MARKET: RESEARCHCONTACTS
FIGURE 30. BIOPHARMACEUTICALS MARKET: RESEARCHARTICLES

List of Tables

TABLE 1. BIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PSORIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HYPERCHOLESTEROLEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HYPERCHOLESTEROLEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ALZHEIMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ALZHEIMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PARKINSONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PARKINSONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HEMOPHILIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY LYSOSOMAL STORAGE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY LYSOSOMAL STORAGE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY MAMMALIAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY MICROBIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY NONVIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY NONVIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HYBRIDOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HYBRIDOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT DNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT DNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY GENERICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY GENERICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BIOPHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 191. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 192. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 193. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2018-2024 (USD MILLION)
TABLE 194. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2025-2030 (USD MILLION)
TABLE 195. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 196. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 197. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 198. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 199. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 200. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 201. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 202. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 203. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 204. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 205. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 208. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 209. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 210. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 211. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 220. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 221. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 224. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 225. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 226. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 227. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 228. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 229. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 230. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 231. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 232. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 233. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 238. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 239. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RARE DISEASE, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY CELL CULTURE, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 334. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (US

Samples

LOADING...

Companies Mentioned

Roche Holding AG
Pfizer Inc.
Johnson & Johnson
Merck & Co., Inc.
AbbVie Inc.
Novartis AG
Sanofi S.A.
Bristol-Myers Squibb Company
Amgen Inc.
Gilead Sciences, Inc.

Table Information

Report Attribute	Details
No. of Pages	195
Published	August 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 690.04 Billion
Forecasted Market Value ( USD ) by 2030	$ 1100 Billion
Compound Annual Growth Rate	9.8%
Regions Covered	Global
No. of Companies Mentioned	10

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3147EUR$3,545USD£2,730GBP €3497EUR$3,939USD£3,034GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3395EUR$3,824USD£2,945GBP €3772EUR$4,249USD£3,272GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4602EUR$5,183USD£3,992GBP €5113EUR$5,759USD£4,435GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5568EUR$6,272USD£4,830GBP €6187EUR$6,969USD£5,367GBP

Biopharmaceuticals Market by Therapeutic Area (Autoimmune, Cardiovascular, Infectious Disease), Technology (Cell Culture, Gene Therapy, Hybridoma), Distribution Channel, Product Type, Route Of Administration, Distribution Channel - Global Forecast 2025-2030

Market Snapshot: Biopharmaceuticals Market Growth and Trajectory

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact on the Biopharmaceuticals Market

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Samples

Companies Mentioned

Table Information

Market Snapshot: Biopharmaceuticals Market Growth and Trajectory

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact on the Biopharmaceuticals Market

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Samples

Companies Mentioned

Table Information

Related Topics

Related Reports

Biopharmaceutical CMO & CRO Market by Service Type (Analytical, Cell Culture, Clinical Development), Product Type (Large Molecule, Small Molecule), Application, End User - Global Forecast 2025-2030

Biopharmaceuticals Contract Manufacturing Market by Service Type, Product Type, Production Stage, Application, Organisation Size - Global Forecast 2025-2030

Biopharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Monoclonal Antibody, Insulin, Vaccine, Hormone), By Disease, By Drug Type, By Drug Development Type, By Formulation, By Region, And Segment Forecasts, 2025 - 2030

Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report by Source, Service (Process Development), Drug Type (Biologics, Biosimilars), Type, Scale of Operation, Therapeutic Area, Region, and Segment Forecasts, 2025-2030

Biopharmaceutical Market Outlook to 2029